Sign in
4

Changes in Ownership

Entrada Therapeutics, Inc. Filed Acc 0001689375-24-000006

CEO gave up 7,604 shares (to pay taxes)

  • CEO acquired 104,700 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Doshi Dipal CEO 2024-03-01 Grant or award +104,700 347,979 D
Doshi Dipal CEO 2024-03-04 Shares withheld for taxes −1,164 $12.42 $14,460 346,815 D
Doshi Dipal CEO 2024-03-04 Shares withheld for taxes −1,391 $13.37 $18,594 345,424 D
Doshi Dipal CEO 2024-03-05 Shares withheld for taxes −5,049 $12.28 $61,996 340,375 D
Derivatives
Doshi Dipal CEO 2024-03-01 Grant or award · Stock Option (Right to Buy) +158,500 158,500 D
Loading xslF345X05/wk-form4_1709686121.xml…